Fig. 3From: A cross-sectional study on the prevalence of cardiovascular disease in elderly patients with long-term type 2 diabetes mellitus mainly attended in private clinics in Mexico. The CAPTURE studyUse of glucose lowering drugs with proven CV benefit stratified by CVD subtype in Mexico. *Liraglutide, semaglutide, dulaglutide **Empagliflozin, canagliflozin, dapagliflozin. ASCVD: atherosclerotic cardiovascular disease; CV: cardiovascular; CVD: cardiovascular disease; GLP-1RA: glucagon-like peptide-1 receptor agonist; SGLT2i: sodium-glucose co-transporter-2 inhibitor. Population at risk was defined according to REWIND and DECLARE-TIMI 58 criteria [10, 14]Back to article page